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Abstract.  The T  cell antigen receptor (TCR)  is a  mul- 
tisubunit complex composed of at least seven trans- 
membrane chains.  The predominant species in most T 
cells has the composition otfly6~2.  The roles of 
subunit assembly in transport out of the ER and in the 
recently described process of pre-Golgi degradation of 
newly synthesized TCR chains were analyzed in a 
T-cell line deficient in the synthesis of fi chains (A2) 
and in COS-1  fibroblasts transfected with genes encod- 
ing individual TCR chains.  Studies with the fi-deficient 
T-cell line showed that,  in the absence of fi, the other 
TCR chains were synthesized at normal rates, but,  in- 
stead of being transported to the cell surface, they 
were retained in the ER.  Analysis of the fate of TCR 
chains retained in the ER showed that they were 
degraded at vastly different rates by a  nonlysosomal 
pathway. Whereas the t~ chains were degraded rapidly, 
3;,  ~', and e were relatively long-lived. To analyze 
whether this selective degradation was because of 
different intrinsic susceptibility of the individual chains 
to degradation or to the formation of resistant 
oligomers, TCR chains were expressed alone or in 
combinations in COS-1  fibroblasts. These studies 
showed that (a)  individual TCR chains were degraded 
at different rates when expressed alone in COS-1  cells, 
and (b)  sensitive chains could be stabilized by coex- 
pression with a  resistant chain.  Taken together, these 
observations indicate that both intrinsic sensitivity and 
subunit assembly play a  role in determining the rates 
at which newly synthesized TCR chains are degraded 
in the ER. 
ECENT studies have demonstrated that cells are cap- 
able  of preventing the  expression  of abnormal  or 
incompletely assembled membrane multisubunit com- 
plexes on their surface. Mutations that alter the conformation 
of components of homoligomeric complexes frequently re- 
sult in their failure to be transported to the cell surface (Kreis 
and Lodish,  1986;  Gething et al.,  1986;  Copeland et al., 
1986).  In some cases, these changes completely abolish the 
ability of the proteins to oligomerize. In other cases, the as- 
sembly of oligomers is not affected, but the complexes have 
abnormal conformations. Likewise, the lack of synthesis of 
individual chains of membrane heteroligomeric complexes 
also causes intracellular retention of the remaining chains 
(Weiss  and Stobo,  1984;  Furley et al.,  1986;  Rein et al., 
1987; Sussman et al.,  1988;  Chen et al.,  1988).  Two basic 
mechanisms underlie the failure to express incomplete com- 
plexes on the cell surface: (a) retention of newly synthesized 
proteins within the ER (reviewed by Rose and Doms, 1988); 
and (b) selective degradation of abnormal proteins and pro- 
tein complexes (Minami et al., 1987; Sussman et al., 1988; 
Lippincott-Schwartz et al.,  1988a;  Chen et al.,  1988).  The 
presence of such mechanisms implies that cells have evolved 
the ability to edit the architecture of newly synthesized pro- 
teins and protein complexes. This editing prevents mistaken 
structures from reaching the cell surface or surviving within 
the cells. 
We have been studying the nature of such structural editing 
mechanisms using the T-cell  antigen receptor (TCR) ~ as a 
model. The TCR is one of the most complex surface recep- 
tors described to date. It is composed of at least seven trans- 
membrane chains (Samelson et al.,  1985;  Oettgen et al., 
1986).  In most T cells, the TCR comprises two immuno- 
globulin-like variable chains, ot and fl, which are responsible 
for the ligand recognition function of the receptor, and five 
invariant  chains,  CD3-3,, -tS, -e,  and  the  disulfide-linked 
homodimer ~'z, which probably function in signal transduc- 
tion (reviewed by Allison and Lanier, 1987; Clevers et al., 
1988; Weissman et al., 1988b). In mature T cells, all of these 
chains are expressed on the cell surface as a complex with 
a  minimum stoichiometry of ~fl~/6~2. An additional pro- 
1. Abbreviations used in this paper: TCR, T-cell antigen receptor; Tf, trans- 
ferrin; TRAP, T-cell  antigen receptor-associated protein. 
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et al., 1988b) or CD3-o~ (Pettey et al., 1987; Alarcon et al., 
1988) has been found to interact transiently with the TCR 
chains during assembly of the complex in the ER. 
Early T-cell precursors in the thymus or mutant T cells that 
fail to synthesize some of the receptor chains lack expression 
of the remaining chains on the cell surface, even though these 
chains are  synthesized at normal rates  (Weiss  and Stobo, 
1984; Furley et al., 1986; Sussman et al., 1988; Chen et al., 
1988). Two mechanisms exist within T cells to prevent trans- 
port of incomplete complexes to the cell surface: delivery of 
newly synthesized TCR chains to lysosomes (Minami et al., 
1987;  Sussman  et  al.,  1988)  and  retention  in  the  ER 
(Lippincott-Schwartz et al.,  1988;  Chen et al.,  1988).  The 
delivery of incomplete complexes to lysosomes was observed 
in mutant T  cells deficient in the synthesis of the ~" chains 
(Sussman et al., 1988) and in T-cell hybridomas in which the 
~" chains were synthesized in limiting amounts (Minami et 
al., 1987). In both of these cell lines, c~/~3,~5e  complexes were 
assembled in the ER, transported through the entire Golgi 
system and rapidly degraded by a process sensitive to inhibi- 
tors of lysosomal proteolysis. Immunoelectron microscopy 
studies  have  directly demonstrated the  presence  of TCR 
chains in lysosomes (Chen et al.,  1988).  Retention of TCR 
chains in the ER has been observed in a mutant T cell that 
fails to synthesize any/3 chains (Chen et al.,  1988) and in 
fibroblasts  transfected with  genes  encoding the  a  and  /~ 
chains (Lippincott-Schwartz et al., 1988). Despite their fail- 
ure to be transported to the Golgi system, partial complexes 
were  assembled in these cells.  Surprisingly,  some of the 
receptor chains retained in the ER were found to be rapidly 
and efficiently  degraded by a nonlysosomal process, suggest- 
ing the existence of a new pathway for the degradation of 
newly synthesized membrane proteins (Lippincott-Schwartz 
et al.,  1988;  Chen et al.,  1988). 
In the present study, we have examined the relationship be- 
tween the quaternary structure of receptor complexes, reten- 
tion in the ER and nonlysosomal degradation. To this end, 
we have characterized the effect of a new deficiency in the 
structure of the TCR complex, the lack of CD3-t5 chains, on 
the fate of the individual receptor subunits. In the absence 
of CD3-~5, all of the other TCR chains were synthesized and 
partially assembled in the ER, but failed to be transported 
into the Golgi system. The TCR chains retained in the ER 
were degraded at vastly different rates. While the a  chains 
were rapidly degraded by a nonlysosomal pathway, e, % and 
~" survived for long periods of time. To understand the mech- 
anism(s) underlying this selectivity for degradation, we ex- 
amined the turnover rates of free and assembled chains in 
fibroblasts  transfected with  genes  encoding  TCR  chains. 
When expressed alone in transfected fibroblasts, TCR chains 
were also found to be degraded at different rates, indicating 
that structural information is contained within each chain 
that determines their sensitivity to degradation. When ex- 
pressed in combinations, however,  certain subunit interac- 
tions led to the stabilization of sensitive chains by virtue of 
their assembly into oligomeric structures. This was strik- 
ingly exemplified by the "y chain, which was rapidly degraded 
when expressed alone but was protected from degradation 
when assembled with the ~ chain. Two factors, therefore, ap- 
pear to determine the different fates of individual TCR chains 
retained in the ER: (a) intrinsic sensitivity to degradation, 
and (b) assembly into stable oligomers. 
Materials and Methods 
Specific Reagents 
The followig antibodies were used for immunoprecipitation and morpholog- 
ical studies: anti-~, afffinity-purified anti-peptide antiserum No. 1489 raised 
in a goat immunized with a COOH-terminal peptide of the mouse 6 chain 
(Samelson et al.,  1986);  anti-c~ (A21M-2),  monoclonal mouse IgG2a that 
reacts with a clonotypic determinant of the 21M-t~ chain (Samelson et al., 
1983;  Saito et al., 1987);  anti-e, monoclonal hamster antibodies 145-2C11 
(Leo et al., 1987) and 500A2 (Havran et al., 1987) and polyclonal antiserum 
No. 127 raised in a rabbit immunized with purified mouse ~ (Minami et al., 
1987); anti-'ye, polyclonal antiserum No. 125 raised against purified mouse 
-y and e (A. M. Weissman, unpublished observations); anti-~', polyclonal an- 
tisera No.  124  and  No.  387,  raised in  rabbits immunized with purified 
mouse ~" (Weissman et al.,  1986) or a synthetic peptide comprising amino 
acids 132 to 144 of  the murine ~" sequence (Weissman et al., 1988a), respec- 
tively.  For immunoprecipitation studies, anti-a, -¢, -~,~, and -~" antibodies 
were bound to protein A agarose (Bethesda Research Laboratories, Gaithers- 
burg, MD). Affinity-purified anti-~ antibodies were immobilized by cova- 
lent coupling to CNBr-activated Sepharose beads (Pharmacia Fine Chemi- 
cals, Uppsala, Sweden). Transferrin receptors were isolated with human 
transferrin covalently coupled to CNBr-activated Sepharose. A polyclonal 
rabbit antiserum that reacts with ER resident proteins (Louvard et al., 1982) 
was kindly provided by Dr. D. Louvard (Pasteur Institute, Paris, France). 
Fluorescein-conjugated affinity-purified goat anti-hamster lgG was from 
Kirkegaard &  Perry Laboratories, Inc. (Gaithersburg, MD). Rhodamine- 
conjugated goat  anti-mouse IgG  or  anti-rabbit  IgG  were  from Cappel 
Laboratories (Malvern, PA). Brefeldin A was a gift of Sandoz Ltd. (Basel, 
Switzerland). 
Development of a 5-Deficient Cell Line 
T  cells deficient in the expression of the CD3-t~ chains were obtained by 
repetitive subcloning at limiting dilution of the antigen-specific 21M T-cell 
hybridoma line. Screening for low t5 expressors was performed by immuno- 
blotting with anti-/i antibodies. After four rounds of single cell cloning at 
limiting dilution, a cell line was isolated (called 3.12.29.19)  that expressed 
levels of t5 ,x,50-fold lower than 21M cells. This cell line also expressed very 
low levels of ~" chains. The ~" deficiency was corrected by transfection of the 
~'chain cDNA (Weissman et al., 1988a) inserted into the pFNeo expression 
vector (Saito et al., 1987). Transfection was accomplished by protoplast fu- 
sion as described by Oi et al. (1983) and stable transformants were selected 
with 1 mg/ml G418 (Gibeo Laboratories, Grand Island, NY). Five clones 
were obtained, four of which expressed the ~" chains. One of them, named 
A2, was selected for further analysis. 2B4 and A2 cells were grown in T-cell 
medium, as previously described (Samelson and Schwartz, 1983).  A2 cells 
were treated with 1-2 mM sodium butyrate 16 h before each experiment to 
enhance the expression of the transfected ~" gene as described by Gorman 
et al. (1983).  The addition of sodium butyrate did not cause any effect on 
the processes analyzed in this study, as previously reported (Lippincott- 
Schwartz et al.,  1988).  Under these conditions, A2 cells displayed '~5% 
the number of surface receptors found on the parental line 2114, as deter- 
mined by flow cytofluorometry using an anti-c~ antibody (A2B4-2). 
Expression of TCR Chains in COS4 Ceils 
For transient expression in COS-1 fibroblasts, cDNAs encoding the 2B4-c~ 
and the murine 7, ~, and ~" chains were cloned into the expression vector 
pSVL (Pharmacia Fine Chemicals). A  PBS plasmid (Stratagene Cloning 
Systems, La Jolla, CA) containing a 1.6-kb insert encoding the 2B4-tx cDNA 
(provided by Dr. S. M. Hedrick, University of California, San Diego) was 
cut with Xba I to release a 1.3-kb fragment comprising all of  the 2B4-c~ coding 
sequences (Chien et ai., 1984; Saito et al., 1984; Becker et al., 1985). This 
fragment was cloned into the Xba I site of pSVL. The orientation of the in- 
sert was determined by digestion with Pvu II. A 0.7-kb fragment encoding 
the mouse CD3w chain (Krissansen et al., 1987) was cut with F.co RI from 
a  pUC 9  vector (pBI0.AT33,-1,  provided by Dr.  M. Crumpton, Imperial 
Cancer Research Fund, London, England). This fragment was cloned into 
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convenient flanking restriction sites. The 3, cDNA was then released with 
Xba I and Barn HI and ligated to an Xba I-Barn HI digest of pSVL. The 
mouse CD3-e cDNA (Gold et al.,  1987) was excised as a  1.5-kb fragment 
from a pGEM-1 vector (pDL1, provided by Dr. D. P. Gold, Medical Biology 
Institute, La Jolla, California) using Eco RI. The recessed ends were filled 
in using Klenow fragment and the blunt-ended cDNA was cloned into the 
Sma I site of pSVL. The orientation was tested with Xho I. A Kpn I to Eco 
RI fragment of the murine zeta cDNA (Weissman et al., 1988a) was ligated 
into pGEM-4Z. After cloning this fragment, the vector was cut with Eco 
RI, the recessed end filled as above and then cut with Xba I (contained within 
the polylinker). This fragment was isolated and ligated into pSVL, which 
had been cut with Xba I and Sma I. 
Calcium phosphate precipitates containing 20-30 tzg plasmid DNA/mil- 
liliter were prepared essentially as described by Gorman et al., 1982. COS-1 
cells grown to 80-90%  confluency in  150-mm-diam tissue culture dishes 
were incubated for 16 h at 37°C with 1 ml of calcium phosphate-precipitated 
DNA and  10 ml DME containing 10%  FBS and 0.15 mg/ml gentamicin 
(COS cell medium).  The medium was then replaced by fresh COS cell 
medium and the cells were grown for an additional 48 h. Sodium butyrate 
(2 mM) was added to the culture medium 16 h before the experiments, to 
enhance the expression of the transfected genes (Gorman et al.,  1983). 
Metabolic Labeling 
T cells or transfected COS-i cells were preincubated for 15 min at 37°C with 
methionine- or cysteine-free medium (methionine- or cysteine-free RPMI 
1640, Biofluids, Inc., Rockville, MD) containing 5% FBS and 0.15 mg/ml 
gentamicin. Cells were then labeled for 30 min at 37*C with 0.2-0.5 mCi/ml 
[3SS]methionine  (Trans-35S-label,  ICN  Radiochemicals,  Irvine,  CA)  in 
methionine-free medium or I mCi/ml [3SS]cysteine (ICN Radiochemicals) 
in cysteine-free medium and, when indicated, chased for various periods of 
time  in  complete  T-cell  medium.  Labeled  proteins  were  extracted  by 
solubilization in ice-cold 0.5% (wt/vol) Triton X-100, 0.3 M NaCI, 50 mM 
Tris/HCl, pH 7.4 for 15 min. Insoluble material was removed by centrifuga- 
tion for 15 min at maximum speed in a microfuge (Beckman Instruments, 
Inc., Palo Alto, CA) at 4°C. Isolation of labeled TCR chains with anti-TCR 
antibodies and  electrophoretic techniques were as previously described 
(Samelson et al., 1985).  Treatments with endo H (Genzyme, Boston, MA) 
and endo D (Calbiochem-Behring Corp., San Diego, CA) have also been 
described before (Chert et al.,  1988).  Fluorograms were scanned using a 
densitometer (ultroscan XL; LKB Instruments Inc., Bromma, Sweden). 
lmmunofluorescence Microscopy 
Surface TCR chains were stained by incubating intact 2B4 or A2 cells with 
monoclonal anti-or (A2B4-2) or anti-e (500A2)  antibodies for i  h at room 
temperature followed by rhodamine-conjugated goat anti-mouse IgG (1:100 
dilution) or fluorescein-conjugated goat anti-hamster IgG (1:i0 dilution), 
respectively. Excess antibodies were removed by centrifugation in ice-cold 
PBS. For staining of intracellular TCR chains, 2B4 and A2 cells were at- 
tached  to  concanavalin A-coated cover glasses as  previously described 
(Lippincott-Schwartz et al., 1989),  fixed with 2 % formaldehyde in PBS and 
permeabilized with 0.1%  saponin in PBS. Cells were then incubated with 
either anti-~ (A2B4-2) or anti-e (500A2)  in combination with a polyclonal 
anti-ER antiserum for 1 h at room temperature. After washing offthe unbound 
antibodies with PBS for 15 min, cells were incubated for 30 rain at room 
temperature  with either fluorescein-conjugated goat anti-mouse IgG  or 
fluorescein-conjugated goat anti-hamster IgG  together with  rhodamine- 
conjugated goat anti-rabbit IgG at  1:100 dilutions. After an additional  15 
min  wash in  PBS,  coverslips were mounted on glass slides using fluo- 
romount G  (Southern Biotechnology Associates, Birmingham,  AL) and 
examined with an inverted microscope (ICM405; Carl Zeiss, Inc., Thorn- 
wood, NY). 
Results 
TCR Complexes LacMng the ~ Chain Are 
Retained in the ER 
Previous studies have shown that incompletely assembled 
TCR complexes fail to be transported to the cell surface. In- 
terestingly, different structural defects result in different in- 
tracellular fates for the incomplete receptors. When cells fail 
to synthesize one of the components of the o~B clonotypic het- 
erodimer, the other chains are retained in the ER (Chen et 
al.,  1988;  Hannum et al.,  1987; Furley et al.,  1987). Lack 
of synthesis of the ~'2 homodimer, on the other hand, results 
in normal transport of the incomplete complexes from the 
ER into the Golgi system, but these complexes are eventually 
delivered to lysosomes for degradation (Minami et al., 1987; 
Sussman et al.,  1988). The role of the other components of 
the TCR complex (i.e., the invariant 3', t3, and ~ chains) in 
intracellular transport has yet to be addressed.  These pro- 
teins have been shown to form 3"t3c subcomplexes (referred 
to as "CD3") regardless of the presence or absence of the 
other receptor chains (Berkhout et al.,  1988; Bonifacino et 
al.,  1988a).  In addition,  several lines of evidence indicate 
that these proteins are closely related to each other. Genes 
encoding these receptor chains have been localized to the 
same  chromosomal  region and  sequence analysis  has  re- 
vealed a considerable degree of homology, suggesting that 
they may have arisen from a common ancestral gene (Clevers 
et al.,  1988). 
To assess the importance of the components of the CD3 
complex in the intracellular transport and eventual fate of 
TCR chains, we sought to derive a T-cell line deficient in the 
synthesis of a CD3 chain.  A murine T-cell hybridoma line 
named A2, that had steady state levels of t5 chains ~50-fold 
lower than the parental T-cell line 2B4,  was identified and 
isolated as described in Materials and Methods. To analyze 
whether the low content oft3 chains was because of decreased 
biosynthesis, 2B4 and A2 cells were metabolically labeled 
with  pS]methionine or ['S]cysteine, and the TCR chains 
were isolated by immunoprecipitation with specific antibod- 
ies (Fig.  1). Analysis of anti-6 immunoprecipitates by one- 
dimensional SDS-PAGE revealed that A2 cells synthesized 
very low levels of CD3-b chains as compared to the parental 
T-cell line 2B4 (Fig.  1, lanes 1 and 2). Analysis of the same 
samples  by  two-dimensional  nonreducing/reducing  SDS- 
PAGE showed that A2 cells synthesized '~3% the amount of 
t3 chains made by 2134 cells (data not shown). In contrast to 
6, synthesis of the 3', ~', c~, and E chains in A2 cells was com- 
parable to 2B4 cells (Fig. 1). Synthesis of/3 chains could not 
be directly assessed for lack of anti-/3 antibodies. However, 
the a  chains were found to form a disulfide-linked dimer 
both in 2B4 and A2 cells (Fig.  1, lanes 9 and 10). Since the 
2B4-c~ chains do not appear to form homodimers (Bonifacino 
et al.,  1988a), this observation indirectly demonstrated the 
synthesis of/3 chains in A2 cells. Immunoprecipitation with 
anti-3'e antibodies also revealed similar amounts of the tran- 
siently associated protein TRAP in 2B4 and A2 cells (Fig. 
1, lanes 3 and 4). Consistent with the low level of 6 biosyn- 
thesis in A2 cells (Fig.  1, lanes 1 and 2), no t3 chains were 
detected in association with 3' and e (Fig.  1, lanes 3 and 4). 
The appearance of the mature a  chains in 2B4 but not in 
A2 cells after a 30-min pulse with [35S]methionine  (Fig.  1, 
lanes 7-10), suggested abnormal processing of their carbohy- 
drate chains in the &deficient T  cells.  In 2134 cells, the c~ 
chains  are  synthesized as  an  Mr  38,000 precursor that  is 
rapidly  processed  into  a  Mr  42,000-44,000  form  in  the 
Golgi system (Bonifacino et al., 1988b; Lippincott-Schwartz 
et al.,  1988). Likewise, the single N-linked oligosaccharide 
Bonifacino et al.  Pre-Golgi Degradation T-Cell Antigen Receptor Chains  75 Figure 1. Biosynthesis  of TCR chains in 2B4 and A2 cells.  2B4 and A2 cells were pulse labeled  for 30 min at 37°C with  [35S]methionine 
(lanes  1-10), or [3sS]cysteine (lanes 11 and 12), extracted  with 0.5%  Triton X-100, and TCR chains were isolated with anti-~ (anti-serum 
No.  1489; lanes 1 and 2), anti-3,¢ (anti-serum No.  125, lanes 3 and 4), anti-~"  (anti-serum No. 387; lanes 5 and 6), anti-c~ (A2B4-2, lanes 
7-10), and anti-¢ (anti-serum  No.  127; lanes  11 and 12). Immunoprecipitates were analyzed by either one-dimensional SDS-PAGE under 
reducing conditions (lanes  1-8) or two-dimensional  nonreducing/reducing SDS-PAGE (lanes  9-12; nonreducing, left to right; reducing, 
top to bottom).  The positions of molecular weight markers (expressed  as 10  -3 X Mr) appear to the left of the figure. The positions  of TCR 
chains and associated  proteins are indicated.  Lanes 1 and 2, notice the absence of the ~ chain in A2 cells (*). Lanes 3 and 4, the anti-3,¢ 
antibody immunoprecipitates  % TRAP, and 6 from 2134 cells.  The ~ chain in T cells is poorly labeled  with  [3~S]methionine. Notice the 
absence of co-precipitated  6 in A2 cells  (*). Lanes 5 and 6. The anti-~" antibody immunoprecipitates  comparable amounts of ~" from both 
cell  lines.  Lanes 7 and 8, notice the appearance of the mature c~ chain (c~m) in 21M but not in A2 cells.  Lanes 9 and 10, the dotted  line 
marks the position of the diagonal.  Nondisulfide  linked a  appears on the diagonal.  Disulfide-linked  c~/3  dimers appear below the diagonal. 
Lanes 11 and 12. The dotted line marks the position of the diagonal.  The ~ chain, labeled  with  [35S]cysteine, appears as a doublet above 
the diagonal.  T, TRAP; cep, c~ chain precursor; am, mature c~ chain. 
chain of the 3' subunit is terminally processed upon transfer 
into the Goigi system, even though this maturation does not 
result in a change in its electrophoretic mobility (Chen et al., 
1988).  To analyze whether the a  and 3" chains  in A2 cells 
were  transported  into  the  Golgi  system,  cells  were  pulse- 
labeled  for 30  min  with  [35S]methionine  or  pulsed  for 30 
min and chased for 90 min.  The a  and 3" chains were then 
isolated with specific antibodies, and the structure of N-linked 
oligosaccharide chains was examined by digestion with en- 
doglycosaminidases H and D (endo H and endo D). Endo H 
cleaves "high mannose" chains and has been used to monitor 
transport  into  the  medial  Golgi  cisternae  (Tarentino  and 
Maley, 1974; Kornfeld and Kornfeld,  1985). Endo D cleaves 
MansGlcNAc2 intermediates generated during processing of 
high mannose chains in cis Golgi cisternae (Koide and Mura- 
matsu,  1974).  As  expected  from their  location  in  the  ER 
early after synthesis, o~ and 3, chains in A2 cells were sensi- 
tive to endo H  and resistant to endo D  after a  30 min pulse 
(Fig.  2, A and B, PULSE).  In contrast to the processing of 
and 3' carbohydrates observed in 2B4 cells (Bonifacino et 
Figure 2. Lack of Golgi processing of TCR chains in A2 cells.  A2 cells  were pulse labeled  for 30 min at 37°C with  [3SS]methionine and 
then, they were either placed on ice (PULSE) or chased for 90 min at 37°C in complete T-cell medium (CHASE). TCR-c~  (,4) and -~/chains 
(B) and transferrin  receptors (C) were isolated  from detergent-solubilized  cells  using anti-t~ (A2B4-2) and anti-~,~ (No.  125) antibodies 
or transferrin  (Tf)-Sepharose, respectively,  as indicated  in the figure.  Nonspecific  precipitation  controls (NS) were performed using the 
monoclonal antibody F23 (Staerz et al., 1985) (for c0; nonimmune serum (for 30 or protein A-Sepharose (for transferrin  receptors).  Precipi- 
tates were then either not treated  (-) or treated  with endo H (H) or endo D (D) before analysis  by one-dimensional SDS-PAGE under 
reducing conditions.  The positions of molecular weight markers (in  10  -3  X  Mr) appear to the left.  The positions  of TCR chains and the 
Tf receptor are indicated  on the right of the respective  panels. 
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chains in 2B4 and A2 cells by 
immunofluorescence  micros- 
copy. A-D,  intact 2B4 (A-B) 
and A2 cells (C-D) were sur- 
face-stained with the anti-e an- 
tibody 500A2 and fluorescein- 
conjugated goat anti-hamster 
IgG. Cells were examined by 
phase-contrast (A and C) and 
fluorescence  microscopy  (B 
and D). Notice the absence of 
staining on the surface of A2 
cells (D). Bars, 20/zm. E-H, 
2B4 (E-F) and A2 cells (G-H) 
were fixed with formaldehyde, 
permeabilized  with  saponin, 
and incubated with a combina- 
tion of the hamster anti-e an- 
tibody  500A2 and  a  rabbit 
anti-ER antibody, followed by 
fluorescein-conjugated  goat 
anti-hamster IgG and  rhoda- 
mine-conjugated  goat  anti- 
rabbit IgG. E and G, fluores- 
cein channel (anti-e). Fand H, 
rhodamine channel (anti-ER). 
Notice the localization of e in 
the ER of A2 (G and H) but 
not 21M cells (E and F). Bars, 
2.5/zm. 
al.,  1988b;  Chen et al.,  1988),  ct and 3, chains in  A2 cells 
remained sensitive to endo H  after a 90 min chase (Fig. 2, 
A  and B,  CHASE),  indicating  that  they failed to be trans- 
ported into the medial Golgi system. In addition, c~ and 3' re- 
mained resistant to endo D  (Fig. 2, A and B); therefore, we 
concluded that these chains did not accumulate in cis Golgi 
cisternae.  Normal processing of the transferrin receptor in 
A2 cells indicated that the lack of processing of TCR chains 
was not the result of a general defect in carbohydrate process- 
ing or intracellular traffic (Fig.  2  C). 
In agreement with these biochemical data suggesting lack 
of transport of TCR chains into the Golgi system of A2 cells, 
staining of intact 2B4 and A2 cells with anti-c (Fig. 3, A-D) 
or anti-or  antibodies (not shown)  followed by fluorescently 
labeled second antibodies revealed the presence of surface 
receptors in 2B4 but not in A2 cells.  When 2B4 cells were 
permeabilized before immunofluorescent staining,  intracel- 
lular TCR chains were found in cytoplasmic vesicles (Fig. 3 
E),  consistent with their localization in  the Golgi system, 
lysosomes and endosomes, as previously shown (Chen et al., 
1988).  By contrast,  in  A2  cells both e and c~ chains  were 
localized  to  a  reticular  network  identified  as  the  ER  by 
colocalization with an ER marker (Fig. 3,  G and H). Taken 
together,  these  results  indicate  that,  in  the  absence of the 
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normal rates but instead of being transported to the cell sur- 
face; however, they are retained in the ER. 
TCR Chains in A2 Cells Are Degraded at Different 
Rates by a Nonlysosomal Pathway 
The fate of the TCR chains retained in the ER of A2 cells 
was analyzed by pulse-chase labeling and direct immuno- 
precipitation with specific anti-TCR antibodies, as shown in 
Fig. 4. These experiments showed that whereas the ot chains 
were rapidly degraded (t,~2 •30  min), 3" and  ~" were more 
stable (/I/2 4-8 h). The e chains were the most stable of the 
TCR chains (t,j2 >  8 h). 
We next examined the characteristics of the rapid degrada- 
tion ofc~ chains in A2 cells. Our previous studies have shown 
that newly synthesized TCR chains can be degraded by two 
different pathways:  lysosomal (Minami et al.,  1988;  Suss- 
man et al., 1988;  Lippincott-Schwartz et al., 1988) and non- 
lysosomal (Lippincott-Schwartz et al.,  1988;  Chen et al., 
1988). Several characteristics of the degradation of ot chains 
in  A2  cells  suggested that  it occurred  by a  nonlysosomal 
pathway. First, as shown above, degradation of the ot chains 
occurred without processing of oligosaccharide chains in the 
Golgi  system (Fig.  2).  This  would  suggest that  the  TCR 
chains are not transported to lysosomes, since the only well 
established route of transit of newly synthesized membrane 
proteins to lysosomes passes through the entire Golgi system 
(Barriocanal et al., 1986; Green et al., 1987; Sussman et al., 
1988). Second, degradation was selective for particular TCR 
chains (Fig. 4). This selectivity is a hallmark of pre-Golgi, 
nonlysosomal degradation (Chen et al., 1988) and is in con- 
trast to the rather indiscriminate destruction of TCR chains 
in lysosomes (Minami et al.,  1988).  Finally,  inhibitors of 
lysosomal proteolysis, including NI-LCI and leupeptin, and 
the metabolic poisons NaN3 and NaF, failed to block degra- 
dation of ct in these cells (Table I), even though they inhibit 
degradation  of TCR chains  in T-cell hybridomas or  ~'-de- 
ficient T cells (Lippincott-Schwartz et al., 1988; Chen et al., 
1988; Sussman et al.,  1988).  In addition, degradation of o~ 
chains in A2 cells displayed the characteristic sensitivity to 
low temperatures previously reported for the pre-Golgi, non- 
lysosomal pathway (Lippincott-Schwartz et al.,  1988). 
Assembled and Unassembled 3" Chains Are Degraded 
at Different Rates in A2 Cells 
The  strikingly  different  rates  at  which  TCR  chains  are 
degraded in A2 cells could be due to one or both of two possi- 
ble causes. Each TCR chain could have a different intrinsic 
susceptibility  to  pre-Golgi degradation.  Alternatively,  the 
formation of particular oligomeric structures could protect 
otherwise sensitive TCR chains from degradation. As a first 
step to distinguish these possibilities, we compared the rates 
of disappearance of assembled and unassembled 3, chains in 
A2 cells. In these experiments, the amount of assembled 3' 
chains was quantitated using the monoclonal anti-e antibody 
2C11, which causes minimal disruption of the CD3 complex 
(Bonifacino et al.,  1988a). Unassembled 3" chains were iso- 
lated with a polyclonal anti-3'e antibody after removal of the 
assembled 3, with anti-e. After a 30-min labeling period, the 
majority (87 %) of 3, chains were assembled into e-containing 
i  '° 
.Ol 
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Figure 4. Fates of TCR chains in A2 cells. A2 cells were pulse la- 
beled for 30 rain at 37°C with [35S]methionine as indicated in the 
Materials and Methods section. Cells were then chased for different 
periods of time at 37°C with complete T-cell medium. At the times 
indicated,  cells  were  collected  by  centrifugation  and  frozen  at 
-70°C. The cell pellets were then thawed at 4°C and extracted with 
iysis buffer. The TCR chains were isolated with anti-¢ (2C11), anti-~" 
(No. 124), anti-3,~ (No. 125) and anti-or (A21M-2) antibodies. Im- 
munoprecipitates  were analyzed  by one-dimensional  SDS-PAGE 
under reducing conditions (for 3' and c0 or two-dimensional non- 
reducing-reducing  SDS-PAGE (for ~ and D- The relative amount 
of each TCR chain (with respect to time 0) was determined by den- 
sitometric scanning of autoradiograms. The results shown are rep- 
resentative  of at least two  independent  determinations  for each 
receptor chain.  •  e; n, ~  o, "y; •, c~. 
complexes. Examination of the fate of assembled and unas- 
sembled 3' chains revealed a difference in their initial rates 
of disappearance. Whereas assembled 3, was relatively stable 
(t,/2 7 h), unassembled 3' disappeared with a tt/2 of less than 
2 h (data not shown). The loss of unassembled 3" chains could 
result  from  either  an  increased  sensitivity  to  pre-Golgi 
degradation of free with respect to assembled 3" or to associa- 
Table L Characteristics  of  tr and 7 Degradation  in A2 and 
COS-1 Cells 
%  Inhibition 
Treatment  ctA2  ct COS-1  7  COS-I 
(a) None (control)  0  0  0 
(b) NH4CI, 50 mM  0  6  9 
(c) Leupeptin, 0.1  mg/ml  12  0  0 
(d) NAN3, 0.1%/NaF,  20 mM  15  18  0 
(e) 16°C  89  85  95 
A2 or COS- 1 cells transfected with the 2134 c~ or 3, cDNAs were either not treat- 
ed (a, d, and e) or incubated for I  h  at 37°C with 50 mM NH4CI (b) or 0.1 
mg/ml leupeptin (c) before labeling for 20 min at 37°C with [35S]methionine. 
Labeled cells were chased for 0, 2, and 5 h at 37°C (a-d) or 16°C (e) in com- 
plete  T-cell  medium.  NI-LCI  or  leupeptin at  the  concentrations  mentioned 
above (b and c) or a mixture of 0. 1% NaN3 and 20 mM NaF (d) were added 
to the chase medium, as indicated in the table. The ct and "y chains were isolated 
by  immunoprecipitation with the  monoclonal anti-a antibody A2B4  or  the 
polyclonal anti--t¢ antiserum No. 125, respectively. After separation by reducing 
SDS-PAGE,  the intensity of protein bands was quantitated by densitometric 
scanning of autoradiograms. The rates of degradation were calculated assum- 
ing first order kinetics and the percent inhibition by each treatment was deter- 
mined by comparison to the rate of degradation in the control cells (a). 
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inherent to this type of experiment, we decided to examine 
the fates of TCR chains expressed alone or in combinations 
in transfected fibroblasts, to more precisely define the role 
of subunit assembly in pre-Golgi degradation. 
Selective Degradation of TCR Chains Expressed 
in Fibroblasts 
To assess whether individual receptor chains have structural 
information that determines retention in the ER and/or sensi- 
tivity to nonlysosomal degradation, we analyzed the fate of 
the  c~,  3',  e,  and  ~" chains  expressed individually  in  fibro- 
blasts.  To this end,  cDNAs encoding TCR chains were in- 
serted into pSVL, an expression vector containing the SV40 
late promoter, origin of replication and polyadenylation sig- 
nal, and these plasmids were used to transfect COS-1 cells. 
When expressed in COS-1 cells, newly synthesized c~ and 3, 
chains failed to acquire Endo H resistance and Endo D sensi- 
tivity, consistent with their being retained in the ER (Fig. 5). 
The intracellular localization of two other TCR chains, e and 
~', in COS-1 cells, however, was more difficult to determine 
since these chains do not have N-linked oligosaccharides and 
could  not  be localized  morphologically with  the  reagents 
available.  Since we were interested  in  studying the  fate of 
each of the TCR chains when retained in the ER, we needed 
assurance that ~ and ~" were not transported out of the ER to 
the Golgi system. For this purpose,  we used the antibiotic 
brefeldin A, which has been shown to block the transport of 
newly  synthesized  proteins  out  of the  ER  (Takatsuki  and 
Tamura, 1985; Misumi et al.,  1986; Lippincott-Schwartz et 
al.,  1989)  without affecting the efficiency or selectivity of 
pre-Golgi  system degradation  (Lippincott-Schwartz  et  al., 
1989).  The transfected cells were pulse-labeled for 30 min 
with  [35S]methionine  and  chased  for  different  periods  of 
time at 37°C in the presence of brefeldin A. As shown in Fig. 
6, tx chains were degraded, while e and g" survived long term. 
In  contrast  to  what  was  observed in  A2  cells  (Fig.  4),  3' 
chains were almost as rapidly degraded as tx chains (Fig. 6). 
Similar  results  to  these  were  obtained  in  the  absence  of 
brefeldin A, confirming that this drug had no effect on degra- 
dation  (data not  shown).  The experiment shown in  Fig.  7 
demonstrated that the loss of a  and 3" chains observed after 
a  long chase was probably not due to the formation of ag- 
gregates that were insoluble in Triton X-100,  since no addi- 
tional chains could be extracted with SDS. In addition, TCR 
._c 
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Figure 6. Different fates of TCR chains in transfected COS-I cells. 
COS-I cells, expressing the mouse e, g', o~, or 3" chains, were prein- 
cubated  for 30 min at 37°C with  [asS]methionine and then incu- 
bated for different periods of time in complete T-cell medium,  all 
in the continuous presence of  5/zg/ml brefeldin A. TCR chains were 
isolated by immunoprecipitation of detergent-solubilized cells with 
anti-e (No. 127), anti-~'(No. 124), anti-c~ (A2B4-2), or anti-'re (No. 
125). Samples were analyzed by one-dimensional SDS-PAGE under 
reducing conditions. The amount of each chain remaining at every 
time point was determined by densitometric scanning of autoradio- 
grams.  The experiment was repeated two times in the absence of 
brefeldin A, with similar results.  ,,, e; n,  g'; o, 3'; o, or. 
chains were not shed into the extracellular medium, as dem- 
onstrated by the failure to isolate any chains from the culture 
supernatant  (Fig.  7).  The loss of a  and 3' in  COS-1  cells 
had  all  the  characteristics  of the  pre-Golgi  nonlysosomal 
degradation  described  earlier  (Lippincott-Schwartz  et  al., 
1988; Chen et al.,  1988), including the lack of inhibition by 
NH4C1, leupeptin,  NaN3/NaF  and  the  inhibition  at  16°C 
(Table I). These observations indicated that each TCR chain 
has an intrinsic  sensitivity to degradation in the ER that is 
manifested when each chain is expressed alone.  However, 
the different fates of 3' when assembled into oligomers, as in 
A2 cells (Fig,  4),  and when expressed alone,  as in COS-1 
cells (Fig. 6), suggested that oligomerization may modify the 
rate of pre-Golgi degradation. 
Stabilization of the 3" Chains by Assembly with 
To test directly whether assembly of TCR chains can affect 
their susceptibility to pre-Golgi system degradation, the fates 
of 3, and e chains expressed either individually or together 
in COS-1  cells were examined.  As shown in Fig.  8 A,  the 
Figure 5. Lack of Golgi processing of TCR 
chains in transfected COS-I cells. The pro- 
cessing of N-linked oligosaccharide chains 
in o~ (A) and 3, chains (B) expressed in COS- 
1 cells was analyzed as described in legend 
to Fig. 2 for A2 cells. 
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insoluble in Triton X-100 and are not shed into the culture medium. 
COS cells expressing t~ (top) or "r (bottom) were metabolically la- 
beled with [3sS]methionine  for 30 min at 37°C. After removing the 
labeling medium and adding complete T-cell medium, cells were 
either  placed  on  ice  (PULSE) or  incubated  for  6  h  at  37°C 
(CHASE). Cells and supernatants were collected separately. Cell 
pellets were first extracted for 15 min at 4°C  with regular lysis 
buffer (0.5% Triton X-100, 0.3 M NaCI, 50 mM Tris/HCI, pH 7.4). 
The insoluble material was reextracted for an additional 15 min at 
4°C with lysis buffer containing 0.2% SDS. The Triton X-100 ex- 
tracts (lanes 1), SDS extracts (lanes 2) and supernatants (lanes 3) 
were subjected to immunoprecipitation with anti-c~ (top) or anti-~,e 
antibodies (bottom). The positions of molecular weight markers (in 
10  -3  X Mr) appear to the right. 
polyclonal anti-Te antisera No.  125 could be used to immu- 
noprecipitate the 7 and e chains regardless of the state of as- 
sociation.  Immunoprecipitation  analysis  of doubly  trans- 
fected cells  with  this  antibody  revealed  similar  levels  of 
expression of 3' and e (Fig. 8 A, lane 8). These chains were 
efficiently assembled  in  COS-1  cells,  as  demonstrated  by 
their co-precipitation using the monoclonal anti-e antibodies 
2C11 (Fig. 8 A, lane 9) or 500A2 (not shown). Interestingly, 
in the absence of the 3/chains, the e chains were very poorly 
immunoprecipitated by both monoclonal anti-e  antibodies 
2C11 (Fig. 8 A, lane 6) and 500A2 (not shown). This obser- 
vation suggested that these antibodies recognize a conforma- 
tional state of the ~ molecule that is favored by the assembly 
of a 3'e complex. 
Analysis  of the  time  course  of degradation  revealed  a 
dramatic stabilization of the "y chains by the simultaneous ex- 
pression of ~ (Fig.  8, B and  C).  This observation demon- 
strated that chains that are sensitive to pre-Golgi, nonlyso- 
somal  degradation can be rendered resistant by assembly 
with intrinsically stable chains. In contrast to these results, 
when 7 and 2B4-et chains were co-expressed in COS-1 cells, 
they did not form stable complexes and their rates of degra- 
dation were the same as when they were expressed alone 
(data not shown). Taken together, these studies suggest that 
intrinsic sensitivity of individual TCR chains to pre-Golgi 
degradation and the ability of these chains to oligomerize 
both play important roles in determining the rates at which 
these chains are degraded while retained in the ER. 
Discussion 
Multiple Signals for Retention in the ER 
Sorting or targeting signals can be defined as structural fea- 
tures within proteins that determine their cellular localiza- 
tion and transport. Signals can occur in the form of prosthetic 
groups, defined amino acid sequences, or conformational de- 
terminants. In its broadest sense, the definition of signal also 
applies to more variable and less well-defined physicochemi- 
cal  characteristics of proteins  (e.g.,  hydrophobic regions, 
formation of aggregates). Retention of proteins in the ER has 
been shown to be mediated by at least two classes of signals. 
The first class of signals includes linear stretches of amino 
acids,  the  best  characterized of which  is  the tetrapeptide 
KDEL found at the COOH terminus of several resident ER 
proteins (Munro and Pelham,  1987).  This structural motif 
appears  to  lae responsible  for the  retention of proteins in 
the ER (Munro and Pelham,  1987), or in an ER-cis Golgi 
cycling pathway (Pelham,  1988), presumably by binding to 
a  specific receptor. A  second less specific mechanism ap- 
pears to operate for the retention of proteins that lack this sig- 
nal. A number of studies over the past few years have shown 
that the conformation of newly synthesized proteins can de- 
termine whether they are transported out of the ER or are 
retained (for review, see Rose and Doms,  1988). The exact 
nature of the signals involved in this retention mechanism is 
not known. Two alternative and not mutually exclusive possi- 
bilities are that malfolded proteins or incompletely assem- 
bled complexes either have signals for retention in the ER or 
lack signals for transport to the Golgi system. 
We have shown that incomplete assembly of some TCR 
complexes results in their retention in the ER. This retention 
is most probably mediated by the same mechanism that acts 
on  malfolded  or  oligomerization-defective proteins.  Irre- 
spective of the actual mechanism, the multiprotein structure 
of the T-cell antigen receptor provided us with an opportu- 
nity to test whether any single subunit possesses the informa- 
tion that  determines retention in  the  ER.  The studies  re- 
ported in this paper, and previous studies, have shown that 
a number of incomplete structures all possess the informa- 
tion that leads to retention in the ER. Complexes lacking the 
/~ (Chen et al., 1988), c~ (Furley et al., 1987; Hannum et al., 
1987), or 8 chains (this study) as well as ct,/$, and "y chains 
expressed separately in fibroblasts (this study; Lippincott- 
Schwartz et al., 1988) all fail to be transported into the Golgi 
system. These observations support the idea that information 
that causes retention in the ER is not the property of a single 
TCR chain or configuration. 
One of the unique observations made with the TCR com- 
plex is that not all subunit deficiencies result in retention in 
the ER.  For instance,  association of the  g'2 homodimer is 
not required for the efficient transport of TCR complexes 
into the Golgi system (Minami et al.,  1987; Sussman et al., 
1988). This observation defines the minimum T-cell receptor 
complex that to date has  been found to be competent for 
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1 cells expressing the mouse 3' (lanes 1-3)  or ~ chains (lanes 4-6), 
or  both  3,  and  e  (lanes  7-9)  were  metabolically  labeled  with 
[35S]methionine  for  30  rain  at  37°C.  After  solubilization  with 
0.5 % Triton X-100, TCR chains were isolated by immunoprecipita- 
tion with either the polyclonal anti-7e antiserum  No.  125 or the 
monoclonal anti-¢ antibody, 2C11. The polyclonal anti-~"  antiserum 
No. 123 was used as a control for nonspecific (NS) immunoprecipi- 
tation. The positions of molecular weight markers (in l0  -3  ×  Mr) 
appear to the left. The positions of the E and 3, chains are indicated 
on the right.  (B) After labeling for 30 rain at 37°C  with [35S]me- 
thionine,  COS-I  cells transfected with -t alone, or 3, and ~, were 
efficient transport  into the Golgi system:  a~'ybe.  This com- 
plex, however, is not efficiently transported to the cell surface 
but is delivered to lysosomes for degradation (Minami et al., 
1987;  Sussman  et al.,  1988). 
Susceptibility to Pre-Golgi Degradation Is an Inherent 
Property of Each TCR Subunit 
Our  previous  studies  have  shown  the  existence  of a  non- 
lysosomal pathway for the degradation of newly synthesized 
proteins,  localized  to the  ER or a  closely  related organelle 
(Lippincott-Schwartz  et al.,  1988;  Chen et al.,  1988).  In T 
cells that synthesize  all of the TCR chains,  complete com- 
plexes are assembled in the ER and rapidly transported  into 
the Golgi system. However, in variant T cells that fail to syn- 
thesize some of the receptor chains or in fibroblasts that ex- 
press  individual  TCR  chains,  partial  complexes  or  free 
chains are retained in the ER, where they undergo selective 
degradation  (this  study;  Chen  et  al.,  1988;  Lippincott- 
Schwartz  et  al.,  1988).  Similarly,  blocking  transport  be- 
tween the ER and the Golgi system in normal T  cells using 
pharmacological  agents  such  as  monensin  or  brefeldin  A 
results in degradation of some of the receptor chains (Lippin- 
cott-Schwartz et al.,  1988).  Comparison of the fates of TCR 
chains  in  the  various  T-cell  lines  studied  has  uncovered  a 
common pattern of selective degradation:  whereas the e, % 
and  ~" chains  are  stable  and  survive  long  term (this  study; 
Chen  et ai.,  1988)  the  ct,  ~,  and  5  chains  are rapidly  and 
efficiently degraded  (this study;  Lippincott-Schwartz  et al., 
1988; Chen et al.,  1988).  The different fates could be the re- 
sult  of (a)  an intrinsic  susceptibility  of each  TCR chain  to 
degradation by the pre-Golgi, nonlysosomal pathway; (b) an 
effect of subunit  interactions  on the  sensitivity  to degrada- 
tion;  or  (c) a  combination  of both  factors. 
To distinguish between these possibilities, genes encoding 
individual TCR chains were transfected into COS-1 cells and 
the  fate  of individual  chains  examined.  We observed  that, 
even when expressed alone, TCR chains are degraded at very 
different rates. Thus, it appears that structural features within 
each chain determine  not only retention  in the endoplasmic 
reticulum  but also whether they are to be degraded  or not. 
Since  we  have  not  yet established  the  identity  of the  pre- 
Golgi  degradative  organelle,  we  cannot  ascertain  whether 
this  differential  degradation  is a  reflection  of the quality  of 
TCR chains as substrates  for proteolytic enzymes or repre- 
sents the probability  of being  sorted to a  degradative  com- 
partment.  In favor of the first possibility,  it should  be noted 
that cellular proteases exist that have a  relatively  restricted 
specificity.  For  instance,  Ca2+-dependent  neutral  proteases 
present  in human erythrocytes degrade the membrane pro- 
teins designated band 2.1 and 4.1 but do not act on other pro- 
teins  (Pontremoli  et al.,  1984).  This differential  sensitivity 
appears to be due to a requirement for specific sequences that 
chased for the times indicated in the figure at 37°C.  Gamma chains 
were isolated by immunoprecipitation with the polyclonai anti--~e 
antiserum No. 125 and resolved by SDS-PAGE under reducing con- 
ditions.  (C) Bands shown in B were scanned by densitometry and 
the results were plotted as the percentage of the initial 3, remaining 
at each time point,  e,  3, alone;  o,  3, (+¢).  Notice the dramatic 
stabilization of the 3' chains produced by co-expression with ~. 
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the very active lysosomal proteases show some selectivity. 
For  instance,  dinitrophenylated  serum  albumin  and  anti- 
dinitrophenyl IgG internalized as a complex via Fc receptors 
in macrophages were found to be degraded at very different 
rates  upon  delivery  to  lysosomes  (Mellman  and  Plutner, 
1984). 
Formation of Stable Oligomers Can Modify the 
Rate of Degradation 
Results  from  a  number of studies have suggested  there is 
greater  resistance  to  intracellular proteolysis displayed by 
oligomers compared to monomers.  For instance, hemoglo- 
bin monomers have been shown to he much more efficiently 
degraded by cytosolic proteases than tetramers (Melloni et 
al., 1984). Similarly, monomers of the influenza hemaggluti- 
nin precursor HAO are more sensitive than trimers to cleav- 
age by several proteases in vitro (Gething et al., 1986; Cope- 
land  et  al.,  1986).  These  observations  suggest  that  sites 
sensitive to cleavage by proteases can be masked by the as- 
sociation of protein monomers. Our studies with the TCR in- 
dicate that even though each receptor chain has a characteris- 
tic sensitivity to pre-Golgi degradation, oligomerization can 
result in stabilization of the sensitive chains. This is indicated 
by the stability displayed by the 3' chains when they are bound 
to the intrinsically stable e chains (Fig.  7).  Not all subunit 
interactions within the TCR complex result in increased re- 
sistance to degradation for the individual chains, however. 
For instance,  5 chains in the/3-deficient T-cell  line 21.2.2 
(Chen et al.,  1988), c~ chains in the tS-deficient line z~2 (this 
study; our unpublished observations), or c~ and ~  chains in 
normal T cells treated with pharmacological agents that pre- 
vent movement out of the ER (Lippincott-Schwartz et al., 
1988) are assembled with the stable e3, core, but are never- 
theless efficiently degraded by the nonlysosomal pathway. 
What is the explanation for the diverse effect of assembly 
on the degradation of TCR chains? The topological localiza- 
tion of cleavage sites within the complexes may have an im- 
portant role.  Masking of specific  sequences recognized by 
endoproteases may lead to an increased stability of the as- 
sembled subunits. By contrast, if the cleavage sites continue 
to be exposed in the complexes,  assembly  will not modify 
the rate of degradation. An alternative explanation is that ct, 
/3, and t5 may be stable as long as they remain within a com- 
plex, but may undergo a time-dependent dissociation within 
the ER if the complex cannot reach the Golgi system.  Dis- 
sociation from the stable e3' dimers would then render the 
free chains susceptible to proteolysis. Whether the enzymes 
that degrade the sensitive chains coexist in the ER with the 
stable e3' dimers or if sorting of the dissociated chains is re- 
quired for degradation to occur, is not known at the present 
time. Further studies are being conducted to differentiate be- 
tween these two possibilities. 
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